Comerica Bank
ENTA icon

Comerica Bank’s Enanta Pharmaceuticals ENTA Stock Holding History

Comerica Bank’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.79K Hold
367
– – ﹤0.01% 3373
2025
Q3 		$4.39K Hold
367
– – ﹤0.01% 3418
2025
Q2 		$2.77K Sell
367
-583
-61% -$3.51K ﹤0.01% 3457
2025
Q1 		$5.24K Buy
+950
New +$5.87K ﹤0.01% 3311
2024
Q2 		– Sell
-333
Closed -$5.81K – 3732
2024
Q1 		$5.81K Buy
+333
New +$4.41K ﹤0.01% 3306
2023
Q4 		– Sell
-75
Closed -$838 – 3760
2023
Q3 		$838 Sell
75
-710
-90% -$11.4K ﹤0.01% 3677
2023
Q2 		$0 Buy
+785
New +$23.1K ﹤0.01% 805
2022
Q4 		$517K Sell
10,732
-3,360
-24% -$153K ﹤0.01% 1757
2022
Q3 		$641K Sell
14,092
-730
-5% -$42.6K 0.01% 1682
2022
Q2 		$755K Sell
14,822
-639
-4% -$34.7K 0.01% 1671
2022
Q1 		$1.17M Buy
15,461
+445
+3% +$29K 0.01% 1500
2021
Q4 		$880K Sell
15,016
-1,295
-8% -$102K 0.01% 1637
2021
Q3 		$1.21M Sell
16,311
-544
-3% -$26.9K 0.01% 1588
2021
Q2 		$819K Sell
16,855
-1,319
-7% -$64.6K ﹤0.01% 1815
2021
Q1 		$914K Sell
18,174
-644
-3% -$32.1K 0.01% 1796
2020
Q4 		$897K Buy
18,818
+81
+0.4% +$3.56K 0.01% 1778
2020
Q3 		$822K Buy
18,737
+1,532
+9% +$74.2K 0.01% 1674
2020
Q2 		$846K Buy
17,205
+1,548
+10% +$80.1K 0.01% 1614
2020
Q1 		$839K Buy
15,657
+623
+4% +$33.2K 0.01% 1458
2019
Q4 		$790K Buy
15,034
+4
+0% +$248 0.01% 1683
2019
Q3 		$895K Buy
15,030
+107
+0.7% +$7.95K 0.01% 1588
2019
Q2 		$1.22M Sell
14,923
-690
-4% -$62.1K 0.01% 1401
2019
Q1 		$1.48M Buy
15,613
+283
+2% +$25.4K 0.01% 1328
2018
Q4 		$1.18M Buy
15,330
+78
+0.5% +$5.98K 0.01% 1448
2018
Q3 		$1.18M Sell
15,252
-87
-0.6% -$8.71K 0.01% 1495
2018
Q2 		$1.9M Buy
15,339
+198
+1% +$19.8K 0.01% 1299
2018
Q1 		$1.31M Buy
15,141
+436
+3% +$33.6K 0.01% 1487
2017
Q4 		$1.06M Sell
14,705
-382
-3% -$19.1K 0.01% 1605
2017
Q3 		$748K Buy
15,087
+510
+3% +$20.5K 0.01% 1741
2017
Q2 		$551K Sell
14,577
-812
-5% -$26K ﹤0.01% 1808
2017
Q1 		$478K Buy
15,389
+558
+4% +$17.4K ﹤0.01% 1881
2016
Q4 		$504K Buy
14,831
+862
+6% +$24.7K ﹤0.01% 1859
2016
Q3 		$363K Buy
13,969
+770
+6% +$17.9K ﹤0.01% 1895
2016
Q2 		$297K Sell
13,199
-395
-3% -$10.3K ﹤0.01% 1934
2016
Q1 		$428K Buy
13,594
+164
+1% +$4.57K ﹤0.01% 1812
2015
Q4 		$397K Buy
13,430
+138
+1% +$4.5K ﹤0.01% 1793
2015
Q3 		$480K Buy
+13,292
New +$571K ﹤0.01% 1727

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Comerica Bank's ENTA Position: Q4 2025 in Review

Comerica Bank held its Enanta Pharmaceuticals (ENTA) position steady in Q4 2025 at 367 shares worth $5.79K. The position accounts for ﹤0.01% of the portfolio, ranked #3373.

Comerica Bank first reported a position in ENTA in Q3 2015 and has held it in 37 quarters since. The position peaked at $1.9M in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q4 2025.

  • Comerica Bank held 367 shares of Enanta Pharmaceuticals worth $5.79K as of Q4 2025.
  • Comerica Bank left its Enanta Pharmaceuticals share count unchanged in Q4 2025.
  • Enanta Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3373 holding.
  • Comerica Bank first reported a position in Enanta Pharmaceuticals in Q3 2015 and has held it in 37 quarters since.
  • Comerica Bank's Enanta Pharmaceuticals position peaked at $1.9M in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.